Buyer
COMMERCIAL MEDICINES UNIT
The tender notices in our corpus from COMMERCIAL MEDICINES UNIT, newest first, read from Find a Tender and Contracts Finder. Each links to its own page and to the original.
- Notices in the corpus
- 58Counted in the corpus search index when this page was read, across every stage (forecast, tender, award, contract). The index is refreshed by the corpus, so the newest notices may be missing for a while.Counted at Fri 23 Oct 2026, 21:21 BST.
- Newest notice published
- 18 Jan 2019
- Buyer type
- OtherThe corpus’s classification from the buyer name, as supplied.
- Read the buyer’s published records, newest first.
- Separate planning, live opportunities and historical outcomes.
- Read the original lot, value basis and documents.
- Investigate relevance before authorising response work.
Which notices has this buyer published?
Open notices are live tenders and forecasts. All notices also include historical ones: awarded, closed or past their deadline.
- Strategic stockpile of medicines 2017COMMERCIAL MEDICINES UNIT · 4 regions · Published 18 Jan 2019This procurement exercise has established a framework agreement which Public Health England will call-off their requirements for the stockpile of emergency medicines.Value not stated in sourceHistorical · Contract
- Dynamic Purchasing System (DPS) for the supply of antibiotics and IV fluidsCOMMERCIAL MEDICINES UNIT · 7 regions · Published 14 Jan 2019The establishment of a dynamic purchasing system (DPS) to allow for the purchase and stockpile of Antibiotics and IV Fluids for the treatment of influenza related secondary bacterial infections. Note that the DPS arrangement shall be valid for a period of 10 years.The Contracting Authority intendValue not stated in sourceHistorical · Contract
- Invitation to offer for NHS National Framework Agreement for the supply of Human Albumin and Human Anti-D ImmunoglobulinCOMMERCIAL MEDICINES UNIT · Any region · Published 17 Aug 2018Invitation to offer for an NHS National Framework Agreement for the supply of Human Albumin and Human Anti-D Immunoglobulin. The period of the framework agreement will be 01.04.17 - 31.03.18 with options to extend for up to a further 36 months. Please refer to Document No.05 for a list of purchasin£21,139,266Estimated value stated in the noticeHistorical · Contract
- NHS National Framework Agreement for the supply of Nitric Oxide Therapy. To include the supply of gas, rental of cylinders and delivery equipment, maintenance and consumablesCOMMERCIAL MEDICINES UNIT · 11 regions · Published 17 Aug 2018NHS National framework agreement for the supply of Nitric Oxide Therapy. To include the supply of gas, rental of cylinders and delivery equipment, maintenance and consumables. The framework will commence on 1st April 2016 for a period of 2 years until 31st March 2018, with options to extend for u£15,000,000Estimated value stated in the noticeHistorical · Contract
- NHS National Framework Agreement for the supply of Recombinant Factor IX products for the treatment of bleeding disordersCOMMERCIAL MEDICINES UNIT · Any region · Published 17 Aug 2018The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England, Wales, Scotland and Northern Ireland. The framework may also be used by private sector contractors and agents working on behalf of the above. Please refer to Document 05d in the ITO£41,000,000Estimated value stated in the noticeHistorical · Contract
- NHS National Framework Agreement for the supply of Human Cell Line Recombinant Factor VIII productsCOMMERCIAL MEDICINES UNIT · Any region · Published 17 Aug 2018NHS National framework agreement for the supply of Human Cell Line Recombinant Factor VIII products. The framework will commence on 1st July 2016 to 31st March 2017, with options to extend for up to a further 39 months. Please refer to the ITO, Document No.05d for a list of Participating Authorities£3,750,000Estimated value stated in the noticeHistorical · Contract
- National Framework Agreement for the Supply of ImmunoglobulinCOMMERCIAL MEDICINES UNIT · 9 regions · Published 17 Aug 2018National Framework Agreement for the Supply of Immunoglobulin Offer reference number: CM/PHS/13/5404 Period of framework agreement: 1st July 2017 to 30th June 2018 with options to extend up to a further 36 months£187,345,245Framework ceiling or programme total, not a contract valueHistorical · Contract
- Contract for the supply of antibiotcs and IV fluids for the treatment of influenza related secondary bacterial infectionsCOMMERCIAL MEDICINES UNIT · 7 regions · Published 30 Nov 2017The Contracting Authority has established a dynamic purchasing system (DPS) and this award notice confirms the completion of the first call off competition. The DPS will be used to maintain a stockpile of various antibiotic and IV products with each individual call off confirming products types andValue not stated in sourceHistorical · Contract
- Antivirals for use in an influenza pandemic, or wide scale epidemicCommercial Medicines Unit · 7 regions · Published 13 Oct 2017This procurement exercise may result in one or more contracts for the provision of antivirals for use in an influenza pandemic, or a wide scale epidemic. The Authority will use any resulting contracts to maintain astockpile of products in the range of 23-38m treatment courses across all 4 lots. TValue not stated in sourceHistorical · Contract
- NHS Framework Agreement for Hepatitis C Medicines for Midlands and East and North of England regionsCOMMERCIAL MEDICINES UNIT · 6 regions · Published 24 Apr 2017NHS framework agreement for Hepatitis C medicines for Midlands and East and North of England regions. Period of framework agreement: 1.3.2017 - 28.2.2018 with an option to extend for up to 12 months.Value not stated in sourceHistorical · Contract
- NHS Framework Agreement for Branded Pharmaceuticals - North of England Tranche A.COMMERCIAL MEDICINES UNIT · North East, North West, Yorkshire and The Humber · Published 24 Apr 2017Branded North of England Branded Medicines - Tranche A - March 2017Value not stated in sourceHistorical · Contract
- NHS Framework Agreement for the Midlands and East Pharmacy Purchasing Group for the supply of Proprietary Pharmaceuticals - Tranche BCOMMERCIAL MEDICINES UNIT · East Midlands, West Midlands, East of England · Published 24 Apr 2017NHS Framework Agreement for the Midlands and East Pharmacy Purchasing Group for the supply of Proprietary Pharmaceuticals - Tranche B£204,758,974Framework ceiling or programme total, not a contract valueHistorical · Contract
- NHS Framework Agreement for Branded Pharmaceuticals - NationalCOMMERCIAL MEDICINES UNIT · 9 regions · Published 24 Apr 2017NHS Framework Agreement for Branded Pharmaceuticals – National£876,875,642Framework ceiling or programme total, not a contract valueHistorical · Contract
- NHS Pharmaceuticals Products Transition 2017_1Commercial Medicines Unit · 12 regions · Published 21 Apr 2017NHS Pharmaceuticals 2017_1 Offer reference number: CM/PHG/15/5490 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months Potential periods of call-offs under the framework agreement: North West & Eastern & North London: 01/05/2£40,000,000Estimated value stated in the noticeHistorical · Contract
- NHS Pharmaceuticals 2016_2COMMERCIAL MEDICINES UNIT · 12 regions · Published 9 Mar 2017Invitation to offer for NHS Pharmaceuticals 2016_2 Offer reference number: CM/PHG/12/5379 Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 36 months Potential periods of call-offs under the framework agreement: North West & Eastern & North L£34,400,000Estimated value stated in the noticeHistorical · Contract
- NHS Pharmaceutical ProductsCommercial Medicines Unit · 13 regions · Published 31 Jan 2017NHS Pharmaceutical Products: Reference number: CM/PHG/15/5467. Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 48 months. Potential periods of call-offs under the framework agreement: Oral Products (100 %); All Regions: 1.3.2017 to 28.2.2019£155,000,000Framework ceiling or programme total, not a contract valueHistorical · Contract
- Contract for the supply of BCG vaccineCOMMERCIAL MEDICINES UNIT · 7 regions · Published 9 Jan 2017The provision of a vaccine to protect against tuberculosis, to be used in the national immunisation programme.Value not stated in sourceHistorical · Contract
- Contract for the supply of rotavirus vaccineCOMMERCIAL MEDICINES UNIT · 7 regions · Published 22 Dec 2016The provision of rotavirus vaccine to be used as part of the national childhood immunisation programme, deliveries will be required from 1 June 2017 to 31 May 2019, with an option to extend for up to an additional 24 monthsValue not stated in sourceHistorical · Contract
- Contract for the supply of herpes zoster (shingles) vaccineCOMMERCIAL MEDICINES UNIT · 7 regions · Published 22 Dec 2016The provision of a vaccine to protect against herpes zoster, to be used in the national immunisation programme,and deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24months.Value not stated in sourceHistorical · Contract
- Contract for the supply of human papillomavrius vaccineCOMMERCIAL MEDICINES UNIT · 7 regions · Published 22 Dec 2016The provision of a vaccine to prevent highgrade cervical intraepithelial neoplasia (CIN grades 2 and 3) and cervical cancer causally related to Human Papillomavirus types 16 and 18, to be used in the national immunisation programme, and deliveries will be required over a period of 2 years, with an oValue not stated in sourceHistorical · Contract
- Contract for the supply of DTaP/IPV/HibCOMMERCIAL MEDICINES UNIT · 7 regions · Published 22 Dec 2016The provision of diphtheria, tetanus, acellular pertussis, inactivated polio vaccine, Haemophilus influenzae type b vaccine (DTaP/IPV/Hib) to be used as part of the national childhood immunisation programme, deliveries will be required from 1 April 2017 to 31 March 2019, with an option to extend forValue not stated in sourceHistorical · Contract
- Contract for the supply of Td/IPVCOMMERCIAL MEDICINES UNIT · 7 regions · Published 22 Dec 2016The provision of low dose diphtheria, tetanus and inactivated polio vaccine (Td/IPV), to be used as part of the national childhood immunisation programme. The contracting authority estimates their requirement over the period of the contract, including the period of the optional extension to be up toValue not stated in sourceHistorical · Contract
- NHS National Pharmaceuticals - Wave 10c Offer reference number: CM/PHG/15/5466 Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 40 months. Potential periods of call-offs under the framework agreement: Oral Products: All Regions 01/07/2017 to 28/02/2019 (20 months) Hospital Only Products: Central and South West (CESW) 01/07/2017 to 30/06/2018 (12 months); North West and Eastern and North London (NWLN) 01/07/2017 to 30/06/2018 (12 months) and South East and South London and North East and Yorkshire (LSNE) 01/07/2017 to 30/06/2018 (12 months)COMMERCIAL MEDICINES UNIT · 12 regions · Published 19 Dec 2016Invitation to offer for NHS National Pharmaceuticals - Wave 10c Offer reference number: CM/PHG/15/5466 Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 40 months. Potential periods of call-offs under the framework agreement: Oral PrValue not stated in sourceHistorical · Contract
- NHS Framework for Supply of Generic Pharmaceuticals Wave 10bCOMMERCIAL MEDICINES UNIT · 12 regions · Published 6 Dec 2016Invitation to offer for NHS Generic Pharmaceuticals Wave 10b Offer reference number: CM/PHG/15/5465 Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 48 months Potential periods of call-offs under the framework agreement: 100% products: All regiValue not stated in sourceHistorical · Contract
- NHS National Framework for Generic Pharmaceuticals - Sevoflurane and VaporisersCOMMERCIAL MEDICINES UNIT · 12 regions · Published 25 Nov 2016NHS National Framework for Generic Pharmaceuticals - Sevoflurane and Vaporisers Period of framework agreement: 32 months with the possibility of an extension of up to a further 16 months Potential periods of call-offs under the framework agreement: 1 August 2016 to 31 March 2019£26,000,000Estimated value stated in the noticeHistorical · Contract
What has this buyer published most recently?
This preview follows the current page’s record order. It is a sample, not a complete history or a forecast.
- 01
- 02
Dynamic Purchasing System (DPS) for the supply of antibiotics and IV fluids
Value not stated in source
- 03
Invitation to offer for NHS National Framework Agreement for the supply of Human Albumin and Human Anti-D Immunoglobulin
Estimated value stated in the notice
- 04
NHS National Framework Agreement for the supply of Nitric Oxide Therapy. To include the supply of gas, rental of cylinders and delivery equipment, maintenance and consumables
Estimated value stated in the notice
- 05
NHS National Framework Agreement for the supply of Recombinant Factor IX products for the treatment of bleeding disorders
Estimated value stated in the notice
How should you check a record before using it?
Follow its notice page to the original publication, then read the current document and value basis.
A published amount may describe a contract, lot or framework ceiling. The wording beside each record states the basis supplied by the source.
Publications: Find a Tender and Contracts Finder.
- Open the linked tender page and its original publication, where recorded.
- Separate publication, award and response dates.
- Read the value basis; a framework ceiling is not money spent.
- Use the named organisation; do not merge a group parent by assumption.
How much time should you allow to review this page?
Multiply the visible record count by your own review time. Follow-up documents are extra work.
Plan this page’s review
25 records on this page × your minutes per record.
Five minutes is an illustration. Later pages and linked documents are additional work.
Estimated review time125 minutesSource: Your inputs and this page · Visible record count
125 minminutes
- First record5
- Remaining records on this page120
Planning estimate for 25 records read at Fri 23 Oct 2026, 21:21 BST; not a measured average or a total for the organisation.
What should you investigate first?
Check the notice’s stage and scope before treating it as available work.
- Record01
Open one relevant notice
Keep its identifier and original publication together. - Context02
Separate invitation from outcome
Planning and award notices are not current invitations. - Evidence03
Read the current documents
Follow scope, lots and updates; resolve missing information through the buyer. - Decision04
Record why it matters
Keep facts separate from eligibility or future-demand assumptions. - Action05
Name a useful follow-up
Decide whether preparation work is justified.
An editorial review sequence, not a buyer timetable or predicted cycle.
What can you safely conclude from these records?
Use the facts each record states. A page of notices or awards does not establish market share, a win rate or future demand.
Review the recorded limitations below. Missing data stays missing, and organisations are linked only when the corpus supplies a page key.
- The corpus and this page are bounded views of published records.
- No organisation-wide spend or awarded-value total is calculated here.
- A named buyer link is not evidence of a wider group relationship.
- Past records do not establish the next opportunity’s date or value.
Where can you investigate next?
Use the guides to resolve the notice stage, framework or evidence question.
| Next record or guide | Purpose |
|---|---|
| Search Contracts Finder records | Understand the next part of the bid |
| Separate frameworks from contracts | Understand the next part of the bid |
| Check the invitation’s stage | Understand the next part of the bid |
| Check security evidence | Understand the next part of the bid |
The next decision needs a record someone can check.
What is the useful next action?
Open a relevant notice and establish whether there is work your team should investigate.
Keep the source, uncertainty and decision together.
Explore current and past tenders →- Locate a relevant published notice.
- Follow original documents and the stage.
- Resolve evidence and delivery questions.
- Keep a specific action and its reasons.
What are the limits of this record?
- Notices are linked to this buyer by a slug made from the buyer name on each notice. A notice that writes the name differently may be under another buyer, or none.
- Buyer type is the corpus's classification from the buyer name, not an official category.
Where was this record read?
- Buyer
- commercial-medicines-unit
- Read at
- Fri 23 Oct 2026, 21:21 BST
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
